Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 62011CA0145

Case C-145/11: Judgment of the Court (Third Chamber) of 19 July 2012 — European Commission v French Republic (Failure of a Member State to fulfil obligations — Directive 2001/82/EC — Veterinary medicinal products — Decentralised procedure for the grant of marketing authorisation for a veterinary medicinal product in a number of Member States — Generic medicinal products similar to the reference medicinal products already authorised — Refusal to approve request by a Member State — Composition and form of the medicinal product)

IO C 295, 29.9.2012, p. 10–10 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

29.9.2012   

EN

Official Journal of the European Union

C 295/10


Judgment of the Court (Third Chamber) of 19 July 2012 — European Commission v French Republic

(Case C-145/11) (1)

(Failure of a Member State to fulfil obligations - Directive 2001/82/EC - Veterinary medicinal products - Decentralised procedure for the grant of marketing authorisation for a veterinary medicinal product in a number of Member States - Generic medicinal products similar to the reference medicinal products already authorised - Refusal to approve request by a Member State - Composition and form of the medicinal product)

2012/C 295/16

Language of the case: French

Parties

Applicant: European Commission (represented by: M. Šimerdová, A. Marghelis and O. Beynet, Agents)

Defendant: French Republic (represented by: G. de Bergues, S. Menez and R. Loosli-Surrans, Agents)

Re:

Failure of a Member State to fulfil obligations — Infringement of Articles 32 and 33 of Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products (OJ 2001 L 311, p. 1) — Decentralised procedure for the grant of marketing authorisation in more than one Member State — Generic medicinal products similar to the reference medicinal products already authorised — Member State’s refusal to approve based on scientific grounds related to the composition of the medicinal product and the choice of pharmaceutical form — Principle of mutual recognition

Operative part of the judgment

The Court:

1.

Declares that, by refusing to approve two requests for marketing authorisation of the medicinal veterinary products CT-Line 15 % Premix and CT-Line 15 % Oral Powder in the context of the decentralised procedure provided for by Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products, as amended by Directive 2004/28/EC of the European Parliament of the Council of 31 March 2004, the French Republic has failed to fulfil its obligations under Articles 32 and 33 of that directive;

2.

Orders the French Republic to pay the costs.


(1)  OJ C 160, 28.5.2011.


Top